These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5768609)

  • 1. Studies on histoplasmosis. V. Protective effect of HIF-coated Histoplasma against challenge.
    O'Hern EM; Fishbein LF; Turner PH
    Mycopathol Mycol Appl; 1969 Jan; 37(1):57-64. PubMed ID: 5768609
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprotection against extrapulmonary histoplasmosis in hamsters.
    Bauman DS; Chick EW
    Am Rev Respir Dis; 1969 Jul; 100(1):82-5. PubMed ID: 5796694
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-protection between Histoplasma capsulatum and Oidiodendron kalrai in mice.
    Tewari RP; Macpherson CR
    Mycopathol Mycol Appl; 1969 Jan; 37(1):97-103. PubMed ID: 5818812
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis.
    Deepe GS; Gibbons R
    Infect Immun; 2001 May; 69(5):3128-34. PubMed ID: 11292732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective antibodies and endemic dimorphic fungi.
    Nosanchuk JD
    Curr Mol Med; 2005 Jun; 5(4):435-42. PubMed ID: 15977999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.
    Scheckelhoff MR; Deepe GS
    J Infect Dis; 2006 Mar; 193(6):888-97. PubMed ID: 16479524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of formalin to kill Histoplasma capsulatum at an epidemic site.
    Tosh FE; Weeks RJ; Pfeiffer FR; Hendricks SL; Greer DL; Chin TD
    Am J Epidemiol; 1967 Mar; 85(2):259-65. PubMed ID: 6067016
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to histoplasmosis induced in mice by components of Histoplasma capsulatum.
    Anderson KL; Marcus S
    Am Rev Respir Dis; 1970 Oct; 102(4):614-22. PubMed ID: 5456424
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of the Francis Medium for the Conversion of Histoplasma capsulatum to the Yeast-Like Growth Phase.
    Novitskaya IV; Zhoga LK; Tereshko DL
    Bull Exp Biol Med; 2019 May; 167(1):62-64. PubMed ID: 31177444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in histoplasmosis. 3. Cross reactions and characterization of Histoplasma and Blastomyces inhibitory factors.
    O'Hern EM
    Mycopathol Mycol Appl; 1967 Apr; 31(3):193-208. PubMed ID: 4961912
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity.
    Deepe GS; Wüthrich M; Klein BS
    Med Mycol; 2005 Aug; 43(5):381-9. PubMed ID: 16178365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thimerosal on the whole yeast phase antigen of Histoplasma capsulatum.
    Pine L; Falcone RG; Boone CJ
    Mycopathol Mycol Appl; 1969 Jan; 37(1):1-14. PubMed ID: 5768605
    [No Abstract]   [Full Text] [Related]  

  • 13. The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells.
    Scheckelhoff M; Deepe GS
    J Immunol; 2002 Nov; 169(10):5818-26. PubMed ID: 12421963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10.
    Deepe GS; Gibbons RS
    J Immunol; 2003 Nov; 171(10):5353-62. PubMed ID: 14607938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis.
    Sá-Nunes A; Medeiros AI; Nicolete R; Frantz FG; Panunto-Castelo A; Silva CL; Faccioli LH
    Microbes Infect; 2005 Apr; 7(4):584-92. PubMed ID: 15820152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of cryptococcosis and histoplasmosis by ketoconazole in athymic nude mice.
    Williams DM; Graybill JR; Drutz DJ; Levine HB
    J Infect Dis; 1980 Jan; 141(1):76-80. PubMed ID: 6988519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
    Nosanchuk JD; Steenbergen JN; Shi L; Deepe GS; Casadevall A
    J Clin Invest; 2003 Oct; 112(8):1164-75. PubMed ID: 14561701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V beta 6+ T cells are obligatory for vaccine-induced immunity to Histoplasma capsulatum.
    Deepe GS; Gibbons R
    J Immunol; 2001 Aug; 167(4):2219-26. PubMed ID: 11490008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration inhibition factor study in Histoplasma capsulatum.
    Anderson KL; Sakaguchi AY
    Mycopathologia; 1978 Sep; 64(1):3-7. PubMed ID: 362217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte stimulation by yeast phase Histoplasma capsulatum in presumed ocular histoplasmosis syndrome.
    Check IJ; Diddie KR; Jay WM; Merker R; Hunter RL
    Am J Ophthalmol; 1979 Mar; 87(3):311-6. PubMed ID: 434090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.